Homo sapiens BCR-ABL1 p190 fusion protein mRNA, partial cds (OK063979)
Homo sapiens AML1-ETO fusion protein mRNA, partial cds (OK063978)
Homo sapiens AML1-ETO fusion protein mRNA, partial cds (OK063977)
Toxicity evaluation of ConvitVax breast cancer immunotherapy
ConvitVax is a personalized vaccine for the treatment of breast cancer, composed of autologous tumor cells, bacillus Calmette-Guérin (BCG) and low concentrations of formalin.
Comentarios recientes